Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community

[1]  D. Tahapary,et al.  Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. , 2022, Diabetes & metabolic syndrome.

[2]  M. Nayor,et al.  Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms , 2022, Current Diabetes Reports.

[3]  M. Elkind,et al.  The American Heart Association's Focus on Primordial Prevention. , 2021, Circulation.

[4]  David A. Hughes,et al.  Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism , 2021, Diabetes.

[5]  Michael J. Gloudemans,et al.  Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes , 2021, medRxiv.

[6]  D. Lloyd‐Jones,et al.  Does Lowering Low‐Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle‐Aged Adults? Analysis of the Observational MESA Study , 2021, Journal of the American Heart Association.

[7]  M. Miyazaki,et al.  Free Deoxycholic Acid Exacerbates Vascular Calcification in CKD through ER Stress-Mediated ATF4 Activation , 2021, Kidney360.

[8]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[9]  Olga V. Demler,et al.  Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women , 2020, Circulation. Genomic and precision medicine.

[10]  Alexander R. Pico,et al.  Metabolic Architecture of Acute Exercise Response in Middle-Aged Adults in the Community. , 2020, Circulation.

[11]  P. Meikle,et al.  Mapping the Associations of the Plasma Lipidome with Insulin Resistance and Response to an Oral Glucose Tolerance Test. , 2020, The Journal of clinical endocrinology and metabolism.

[12]  V. Salomaa,et al.  Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium. , 2019, JAMA cardiology.

[13]  J. Kettunen,et al.  Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study , 2019, BMC Medicine.

[14]  Juan Zhou,et al.  Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions. , 2019, Atherosclerosis.

[15]  J. Manson,et al.  Metabolomic profiles associated with all-cause mortality in the Women's Health Initiative. , 2019, International journal of epidemiology.

[16]  Chen-Yu Liao,et al.  Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice , 2019, bioRxiv.

[17]  T. Esko,et al.  Circulating glucuronic acid predicts healthspan and longevity in humans and mice , 2019, Aging.

[18]  W. Rathmann,et al.  Plasma Metabolomics to Identify and Stratify Patients with Impaired Glucose Tolerance. , 2019, The Journal of clinical endocrinology and metabolism.

[19]  C. Bouchard,et al.  Association of Dimethylguanidino Valeric Acid With Partial Resistance to Metabolic Health Benefits of Regular Exercise. , 2019, JAMA cardiology.

[20]  G. Frost,et al.  Measuring phenotypic flexibility by transcriptome time‐course analyses during challenge tests before and after energy restriction , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  L. Liang,et al.  High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[22]  A. Khera,et al.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[23]  C. Newgard,et al.  Branched-chain amino acids in disease , 2019, Science.

[24]  A. Newman,et al.  Metabolite Profiles of Healthy Aging Index Are Associated With Cardiovascular Disease in African Americans: The Health, Aging, and Body Composition Study , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  E. Ingelsson,et al.  Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance , 2018, Scientific Reports.

[26]  J. Kals,et al.  Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[27]  Emily C. O'Brien,et al.  Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg , 2017, Circulation.

[28]  L. Liang,et al.  Metabolites of Glutamate Metabolism Are Associated With Incident Cardiovascular Events in the PREDIMED PREvención con DIeta MEDiterránea (PREDIMED) Trial , 2016, Journal of the American Heart Association.

[29]  Jerzy Adamski,et al.  Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation Into Cancer and Nutrition–Potsdam Study , 2016, Hypertension.

[30]  Christian Gieger,et al.  Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes , 2016, Diabetologia.

[31]  M. Pletcher,et al.  Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels? , 2015, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

[32]  S. Wopereis,et al.  Phenotypic flexibility as a measure of health: the optimal nutritional stress response test , 2015, Genes & Nutrition.

[33]  J. Murabito,et al.  Distinct Metabolomic Signatures Are Associated with Longevity in Humans , 2015, Nature Communications.

[34]  Anders Larsson,et al.  Large-scale Metabolomic Profiling Identifies Novel Biomarkers for Incident Coronary Heart Disease , 2014, PLoS genetics.

[35]  Andrew W. Correia,et al.  Temporal Trends in the Population Attributable Risk for Cardiovascular Disease: The Atherosclerosis Risk in Communities Study , 2014, Circulation.

[36]  Hannelore Daniel,et al.  Phenotypic flexibility as key factor in the human nutrition and health relationship , 2014, Genes & Nutrition.

[37]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[38]  Hilary A. Godwin,et al.  The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR , 2014, Nature.

[39]  Sunia,et al.  The metabolite alpha-ketoglutarate extends lifespan by inhibiting the ATP synthase and TOR , 2014 .

[40]  R. Vasan,et al.  2-Aminoadipic acid is a biomarker for diabetes risk. , 2013, The Journal of clinical investigation.

[41]  R. Vasan,et al.  Metabolite Profiles During Oral Glucose Challenge , 2013, Diabetes.

[42]  Shih-Jen Hwang,et al.  Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the framingham heart study. , 2012, Journal of the American College of Cardiology.

[43]  E. Rimm,et al.  Alternative dietary indices both strongly predict risk of chronic disease. , 2012, The Journal of nutrition.

[44]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[45]  Fabian J Theis,et al.  The dynamic range of the human metabolome revealed by challenges , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  H. Ashrafian,et al.  Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. , 2011, Trends in microbiology.

[47]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[48]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[49]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[50]  F. Horkay,et al.  Effects of inosine on reperfusion injury after cardiopulmonary bypass , 2010, Journal of cardiothoracic surgery.

[51]  Na Wang,et al.  Hemodynamic Correlates of Blood Pressure Across the Adult Age Spectrum: Noninvasive Evaluation in the Framingham Heart Study , 2010, Circulation.

[52]  Heiner Boeing,et al.  Genetic variation of the FADS1 FADS2 gene cluster and n-6 PUFA composition in erythrocyte membranes in the European Prospective Investigation into Cancer and Nutrition-Potsdam study , 2010, British Journal of Nutrition.

[53]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[54]  Geoffrey S Ginsburg,et al.  Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events , 2010, Circulation. Cardiovascular genetics.

[55]  Bruce M Psaty,et al.  Primary prevention of cardiovascular disease: time to get more or less personal? , 2009, JAMA.

[56]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[57]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[58]  R. Vasan,et al.  Association of Lifestyle Factors With Abdominal Subcutaneous and Visceral Adiposity , 2009, Diabetes Care.

[59]  A. Smilde,et al.  Metabolic Profiling of the Response to an Oral Glucose Tolerance Test Detects Subtle Metabolic Changes , 2009, PloS one.

[60]  Ru Wei,et al.  Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity , 2008, Molecular systems biology.

[61]  G Anfossi,et al.  Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. , 2006, The Journal of clinical endocrinology and metabolism.

[62]  P. Vallance,et al.  Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[63]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[64]  F. Kraemer,et al.  Hormone-sensitive Lipase: Control of Intracellular Tri-(di-)acylglycerol and Cholesteryl Ester Hydrolysis Structural and Biochemical Properties Thematic Review , 2022 .

[65]  J. Tack,et al.  Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans , 2002, Gut.

[66]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[67]  C. Szabó,et al.  Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock1 , 2000, The Journal of Immunology.

[68]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[69]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[70]  W. Kannel,et al.  Some health benefits of physical activity. The Framingham Study. , 1979, Archives of internal medicine.